Incyte Corp. operates within the Commercial physical research sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Incyte Corp. with three other
companies in this sector in the United States:
sales of $853.83 million
of which 70%
Charles River Laboratories International Inc
of which 58%
was Discovery And Safety Assessment), and
PRA Health Sciences Inc
of which 91%
was Clinical Research).
During the year ended December of 2018, sales at
Incyte Corp. were $1.88 billion.
increase of 22.5%
versus 2017, when the company's sales were $1.54 billion.
This was the fifth consecutive year of sales increases at Incyte Corp.
(and since 2013, sales have increased a total of 430%).